5-(2-Ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(4H)-one 2-hydroxypropane-1,2,3-tricarboxylate
10mM in DMSO
- Product Code: 233787
CAS:
171599-83-0
| Molecular Weight: | 666.70 g./mol | Molecular Formula: | C₂₂H₃₀N₆O₄S ·C₆H₈O₇ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD09026931 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used primarily in pharmaceutical research and development, this compound functions as a potent inhibitor targeting specific enzymes involved in cellular signaling pathways. It is particularly investigated for its role in treating cardiovascular diseases and erectile dysfunction due to its ability to selectively inhibit phosphodiesterase enzymes, enhancing blood flow and smooth muscle relaxation. Its formulation with 2-hydroxypropane-1,2,3-tricarboxylate (citric acid) improves solubility and bioavailability, making it suitable for oral dosage forms. Ongoing studies explore its potential in managing pulmonary hypertension and benign prostatic hyperplasia, leveraging its targeted mechanism of action and favorable pharmacokinetic profile.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1ml | 10-20 days | $94.56 |
+
-
|
5-(2-Ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(4H)-one 2-hydroxypropane-1,2,3-tricarboxylate
Used primarily in pharmaceutical research and development, this compound functions as a potent inhibitor targeting specific enzymes involved in cellular signaling pathways. It is particularly investigated for its role in treating cardiovascular diseases and erectile dysfunction due to its ability to selectively inhibit phosphodiesterase enzymes, enhancing blood flow and smooth muscle relaxation. Its formulation with 2-hydroxypropane-1,2,3-tricarboxylate (citric acid) improves solubility and bioavailability, making it suitable for oral dosage forms. Ongoing studies explore its potential in managing pulmonary hypertension and benign prostatic hyperplasia, leveraging its targeted mechanism of action and favorable pharmacokinetic profile.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :